Sivik Global Healthcare’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-45,000
| Closed | -$6.08M | – | 70 |
|
|
2019
Q1 | $6.08M | Buy |
+45,000
| New | +$6.08M | 2.24% | 14 |
|
|
2018
Q4 | – | Sell |
-25,000
| Closed | -$3.48M | – | 63 |
|
|
2018
Q3 | $3.48M | Sell |
25,000
-5,000
| -17% | -$695K | 1.24% | 37 |
|
|
2018
Q2 | $3.73M | Hold |
30,000
| – | – | 1.43% | 36 |
|
|
2018
Q1 | $3.34M | Sell |
30,000
-10,000
| -25% | -$1.11M | 1.56% | 28 |
|
|
2017
Q4 | $4.78M | Sell |
40,000
-20,000
| -33% | -$2.39M | 1.78% | 23 |
|
|
2017
Q3 | $8.42M | Sell |
60,000
-50,000
| -45% | -$7.01M | 2.86% | 6 |
|
|
2017
Q2 | $13.4M | Buy |
110,000
+60,000
| +120% | +$7.3M | 4.9% | 1 |
|
|
2017
Q1 | $6.06M | Sell |
50,000
-10,000
| -17% | -$1.21M | 2.82% | 9 |
|
|
2016
Q4 | $7.34M | Hold |
60,000
| – | – | 3.5% | 6 |
|
|
2016
Q3 | $7.35M | Buy |
60,000
+30,000
| +100% | +$3.68M | 3.71% | 7 |
|
|
2016
Q2 | $3.5M | Sell |
30,000
-20,000
| -40% | -$2.34M | 1.74% | 28 |
|
|
2016
Q1 | $6.96M | Buy |
50,000
+20,000
| +67% | +$2.78M | 3.08% | 6 |
|
|
2015
Q4 | $5.72M | Buy |
30,000
+5,000
| +20% | +$954K | 2.72% | 8 |
|
|
2015
Q3 | $3.91M | Hold |
25,000
| – | – | 1.9% | 22 |
|
|
2015
Q2 | $4.52M | Buy |
25,000
+5,000
| +25% | +$904K | 1.57% | 25 |
|
|
2015
Q1 | $3.47M | Buy |
20,000
+200
| +1% | +$34.7K | 1.18% | 37 |
|
|
2014
Q4 | $3.66M | Sell |
19,800
-5,200
| -21% | -$962K | 1.48% | 29 |
|
|
2014
Q3 | $4.15M | Buy |
25,000
+10,000
| +67% | +$1.66M | 1.88% | 19 |
|
|
2014
Q2 | $2.34M | Buy |
+15,000
| New | +$2.34M | 1.18% | 39 |
|